Pharma, Biotech Bull ETFs Leading the Charge
This article was originally published on ETFTrends.com.
The rising prices of drug treatments, more dependence on immuno-oncology and mergers focused on mid-sized biotech company acquisitions are just a few factors spurning the growth in the biotechnology and pharmaceuticals industry, giving ETFs like Daily Pharmaceutical & Medical Bull 3X Shares (NYSEArca: PILL) and Direxion Daily S&P Biotech Bull 3X ETF (NYSEArca: LABU) exceptional returns. [...]